Steven R. Feldman, MD, PhD
- Professor, Dermatology
Steven R. Feldman, MD, PhD
Research Interests
- Psoriasis
- Dermatologic Agents
- Dermatology
- Lichen Planus
- Folliculitis
- Tinea and Other Fungal Infections
- Education
- PhD, Duke University College of Medicine, 1985
- MD, Duke University School of Medicine, 1985
- Residency
- Duke University Hospital, 1986
- Duke University Hospital, 1987
- University of North Carolina Hospitals, 1990
- Fellowship
- Medical University of South Carolina Medical Center, 1991
- Board Certifications
- American Board of Dermatology, Dermatology
- American Board of Dermatology, Dermatopathology
- Memberships
- American Academy of Dermatology
- Nat'L Psoriasis Foundation
- American Society of Dermatopathology
- Positions
- Professor, Dermatology
- Professor, Social Sciences and Health Policy
- Professor, Pathology
- Departments and Affiliations
- Dermatology
- Social Sciences and Health Policy
- Pathology
Research
- Evaluating Topical JAK Inhibitors as a Treatment Option for Atopic Dermatitis. Fardos MI, Singh R, Perche PO, Kelly KA, Feldman SR. Expert Rev Clin Immunol. 2021 Oct;
- Patient and caregiver preferences on treatment attributes for atopic dermatitis. Ervin C, Crawford R, Evans E, Feldman SR, Zeichner J, Zielinski MA, Cappelleri JC, DiBonaventura M, Takiya L, Myers DE. J Dermatolog Treat. 2021 Oct; :1-9.
- New Onset Inflammatory Bowel Disease in Patient Treated with Secukinumab: Case Report and Review of Literature. Ali AK, Torosian A, Porter C, Bloomfeld RS, Feldman SR. Dermatol Ther. 2021 Oct;
- Assessing Behavioral Economic-Based Approaches to Address COVID-19 Vaccine Hesitancy. Ranpariya VK, Hrin ML, Maghen P, Feldman SR. J Ambul Care Manage. ; 44(4):336-341.
- Methotrexate for pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease) and pityriasis lichenoides chronica: a retrospective case series of 33 patients with an emphasis on outcomes. Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. J Am Acad Dermatol. 2021 Sep;